With over 1,500 attendees from 50+ countries the 2020 edition of World Orphan Drug Congress USA was held online August 24-26. The conference has also become the industry defining meeting on Advanced Therapies for rare diseases, featuring discussions on clinical development, manufacturing and commercialization of cell and gene therapies, as well as the annual gathering for artificial intelligence and digital health solutions transforming the rare disease industry. More information on the conference can be found here.
Delta4 was represented by its CEO and CSO. Several meetings led to promising next steps of partnering and collaboration.
For more information on our orphan drug programs and partnering opportunities contact us directly.